Genprex Inc logo

GNPX

NASDAQ

Genprex Inc

$1.54+0.04 (+2.67%)
Key Statistics
Market Cap$3.57M
P/E RatioN/A
Div. Yield
EPS (TTM)-$17.40
52W High$55.00
52W Low$1.43
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees13
Price Performance
1 Week-15.38%
3 Month-14.44%
1 Year-92.86%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$10.67M
Liabilities$3.25M
Net Income$30.86M loss

About

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company is headquartered in Austin, Texas.

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account
Analyze GNPX with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.